From microbiota to menu: predicting individual responses to dietary components

IF 25.8 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Gut Pub Date : 2025-02-26 DOI:10.1136/gutjnl-2025-334712
Hadar Romano-Zadaka, Nissan Yissachar
{"title":"From microbiota to menu: predicting individual responses to dietary components","authors":"Hadar Romano-Zadaka, Nissan Yissachar","doi":"10.1136/gutjnl-2025-334712","DOIUrl":null,"url":null,"abstract":"Over the past few decades, the prevalence of chronic inflammatory and metabolic diseases has risen sharply, coinciding with significant environmental and lifestyle changes. While genetics play a role, the rapid increase suggests that non-genetic factors are key contributors. Among these, the gut microbiota—a vast community of microorganisms residing in the intestines—has emerged as a central regulator of health. A growing body of evidence links microbial imbalances, or dysbiosis, to various diseases, with reduced microbial richness and diversity observed in industrialised populations compared with those in non-industrialised settings. Many beneficial microbial species, once prevalent in the human gut, are now disappearing, likely due to changes in diet, hygiene and antibiotic use. One of the most influential factors shaping the gut microbiota is diet. The Westernised diet, characterised by high consumption of processed foods and food additives, has been associated with microbiota alterations and linked to conditions such as inflammatory bowel disease, obesity and metabolic disorders. Emerging research suggests that some food additives, including emulsifiers1 and artificial sweeteners,2 may exert their harmful effects through microbiota-mediated mechanisms. However, responses to dietary components are highly heterogeneous across individuals, raising an important question: Can we predict individual responses to diet based on microbiota composition and function? Such predictive capabilities could pave the way for personalised nutrition and medicine, tailoring dietary interventions to an individual’s unique microbial makeup. Despite its promise, this approach faces several challenges. Microbiota composition is highly variable across individuals and influenced by numerous factors, including diet, lifestyle, genetics and prior medical treatments. This variability complicates predicting how specific perturbations will affect an individual’s microbiota, as …","PeriodicalId":12825,"journal":{"name":"Gut","volume":"66 1","pages":""},"PeriodicalIF":25.8000,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gut","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/gutjnl-2025-334712","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Over the past few decades, the prevalence of chronic inflammatory and metabolic diseases has risen sharply, coinciding with significant environmental and lifestyle changes. While genetics play a role, the rapid increase suggests that non-genetic factors are key contributors. Among these, the gut microbiota—a vast community of microorganisms residing in the intestines—has emerged as a central regulator of health. A growing body of evidence links microbial imbalances, or dysbiosis, to various diseases, with reduced microbial richness and diversity observed in industrialised populations compared with those in non-industrialised settings. Many beneficial microbial species, once prevalent in the human gut, are now disappearing, likely due to changes in diet, hygiene and antibiotic use. One of the most influential factors shaping the gut microbiota is diet. The Westernised diet, characterised by high consumption of processed foods and food additives, has been associated with microbiota alterations and linked to conditions such as inflammatory bowel disease, obesity and metabolic disorders. Emerging research suggests that some food additives, including emulsifiers1 and artificial sweeteners,2 may exert their harmful effects through microbiota-mediated mechanisms. However, responses to dietary components are highly heterogeneous across individuals, raising an important question: Can we predict individual responses to diet based on microbiota composition and function? Such predictive capabilities could pave the way for personalised nutrition and medicine, tailoring dietary interventions to an individual’s unique microbial makeup. Despite its promise, this approach faces several challenges. Microbiota composition is highly variable across individuals and influenced by numerous factors, including diet, lifestyle, genetics and prior medical treatments. This variability complicates predicting how specific perturbations will affect an individual’s microbiota, as …
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
从微生物群到菜单:预测个体对饮食成分的反应
在过去的几十年里,慢性炎症和代谢性疾病的患病率急剧上升,同时环境和生活方式也发生了重大变化。虽然遗传因素起了作用,但这种快速增长表明,非遗传因素是关键因素。其中,肠道微生物群——居住在肠道中的庞大微生物群落——已经成为健康的中心调节器。越来越多的证据表明,微生物失衡或生态失调与各种疾病有关,与非工业化环境相比,工业化人群中观察到的微生物丰富度和多样性有所减少。许多曾经普遍存在于人类肠道的有益微生物物种现在正在消失,这可能是由于饮食、卫生和抗生素使用的变化。影响肠道菌群形成的最重要因素之一是饮食。西化饮食的特点是大量食用加工食品和食品添加剂,这与微生物群的改变有关,并与炎症性肠病、肥胖和代谢紊乱等疾病有关。新的研究表明,一些食品添加剂,包括乳化剂和人工甜味剂,可能通过微生物介导的机制发挥其有害作用。然而,个体对饮食成分的反应是高度异质性的,这就提出了一个重要的问题:我们能否根据微生物群的组成和功能来预测个体对饮食的反应?这种预测能力可以为个性化营养和医学铺平道路,根据个人独特的微生物组成定制饮食干预。尽管前景光明,但这种方法面临着一些挑战。微生物群的组成因人而异,并受到许多因素的影响,包括饮食、生活方式、遗传和既往治疗。这种可变性使预测特定的扰动如何影响个体的微生物群变得复杂,因为……
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Gut
Gut 医学-胃肠肝病学
CiteScore
45.70
自引率
2.40%
发文量
284
审稿时长
1.5 months
期刊介绍: Gut is a renowned international journal specializing in gastroenterology and hepatology, known for its high-quality clinical research covering the alimentary tract, liver, biliary tree, and pancreas. It offers authoritative and current coverage across all aspects of gastroenterology and hepatology, featuring articles on emerging disease mechanisms and innovative diagnostic and therapeutic approaches authored by leading experts. As the flagship journal of BMJ's gastroenterology portfolio, Gut is accompanied by two companion journals: Frontline Gastroenterology, focusing on education and practice-oriented papers, and BMJ Open Gastroenterology for open access original research.
期刊最新文献
Circulating extracellular vesicle long RNA profiling combined with machine learning unveils novel diagnostic signature and molecular features in chronic pancreatitis. Loss of sinusoidal endothelial identity: RAP1A at the crossroads of capillarisation and liver fibrosis. Targeting PKM2-dependent glycolysis reprogrammes monocytes into Cadm1+ macrophages to promote mucosal repair and attenuate colitis progression. CD16+ γδ T cells mediate antibody-dependent cellular cytotoxicity and associate with viral control in chronic hepatitis B virus infection. Percutaneous needle decompression for endoscopic iatrogenic pneumoperitoneum: assessment of safety and efficacy in real world practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1